Stock Fundamentals

Company Information

Company Name
Rxsight Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US78349D1072
CIK: 0001111485
CUSIP: 78349D107
Currency: USD
Full Time Employees: 461
Phone: 949 521 7830
Fiscal Year End: December
IPO Date: Jul 30, 2021
Description:

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Address:

100 Columbia, Aliso Viejo, CA, United States, 92656

Directors & Officers

Name Title Year Born
Dr. Ronald M. Kurtz M.D. President, CEO & Director 1963
Dr. Ilya Goldshleger Ph.D. Chief Operating Officer 1975
Mr. Eric J. Weinberg Chief Business Development Officer 1961
Mr. Mark Wilterding Chief Financial Officer 1978
Mr. Oliver Moravcevic Vice President of Investor Relations NA
Mr. Jim Schindler Executive VP & General Counsel NA
Ms. Maureen O'Connell Executive VP of Clinical & Regulatory Affairs NA
Mr. Patrick Cullen Executive VP of Quality & Infrastructure Operations NA
Mr. Adam Dashe Executive Vice President of International NA
Mr. Trent Campbell Executive VP of US Sales & Commercial Strategy NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 12, 2025 Tamara Fountain N/A Sale 7.00K $25.71 $179.97K
Jan 22, 2025 Shweta Maniar N/A Sale 3.52K $30.87 $108.63K
Jan 15, 2025 Jesse Anderson Corley N/A Purchase 1.44K $31.18 $44.99K
Nov 29, 2024 Ilya Goldshleger N/A Sale 3.11K $46.08 $143.08K
Nov 26, 2024 Ilya Goldshleger N/A Sale 3.10K $45.88 $142.23K
Nov 26, 2024 Shweta Maniar N/A Sale 3.78K $45.88 $173.52K
Nov 22, 2024 Ilya Goldshleger N/A Sale 3.10K $45.00 $139.50K
Nov 18, 2024 Ilya Goldshleger N/A Sale 3.10K $45.00 $139.50K
Nov 15, 2024 Ilya Goldshleger N/A Sale 4.88K $46.00 $224.25K
Nov 12, 2024 Jesse Anderson Corley N/A Purchase 11.11K $45.37 $504.11K
Nov 12, 2024 Ilya Goldshleger N/A Sale 1.33K $46.13 $61.35K
Oct 30, 2024 Ilya Goldshleger N/A Sale 3.11K $51.91 $161.18K
Oct 28, 2024 Ilya Goldshleger N/A Sale 3.10K $50.64 $156.98K
Oct 25, 2024 Ilya Goldshleger N/A Sale 3.10K $49.79 $154.35K
Oct 22, 2024 Ilya Goldshleger N/A Sale 3.10K $49.68 $154.01K
Oct 18, 2024 Ilya Goldshleger N/A Sale 3.11K $50.09 $155.53K
Oct 16, 2024 Ilya Goldshleger N/A Sale 3.10K $49.78 $154.32K
Oct 14, 2024 Ilya Goldshleger N/A Sale 3.10K $50.09 $155.28K
Oct 11, 2024 Ilya Goldshleger N/A Sale 3.10K $50.19 $155.59K
Oct 08, 2024 Ilya Goldshleger N/A Sale 3.10K $48.26 $149.61K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 3.19M Mar 31, 2026 7.70% $0.00 17.82%
Vanguard Group Inc 2.23M Dec 31, 2025 5.39% $0.00 3.84%
Millennium Management LLC 2.06M Mar 31, 2026 4.97% $0.01 -3.27%
Artisan Partners Limited Partnership 2.06M Mar 31, 2026 4.97% $0.02 -4.57%
Nomura Holdings Inc 2.00M Mar 31, 2026 4.83% $0.03 0.00%
No Street GP LP 2.00M Mar 31, 2026 4.83% $0.82 1.27%
D. E. Shaw & Co LP 1.96M Mar 31, 2026 4.73% $0.01 4.03%
Vanguard Capital Management, LLC 1.69M Mar 31, 2026 4.09% $0.00 0.00%
Two Sigma Investments LLC 1.30M Mar 31, 2026 3.14% $0.01 62.87%
Bank of America Corp 1.21M Mar 31, 2026 2.92% $0.00 30.31%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 1.13M Mar 31, 2026 2.73% $0.01 761.04%
Citadel Advisors Llc 1.12M Mar 31, 2026 2.70% $0.00 6.97%
Federated Hermes Inc 1.08M Mar 31, 2026 2.61% $0.01 153.90%
Jacobs Levy Equity Management, Inc. 1.07M Mar 31, 2026 2.58% $0.03 476.01%
Acadian Asset Management LLC 1.02M Mar 31, 2026 2.46% $0.01 1,374.60%
Deutsche Bank AG 962.31K Mar 31, 2026 2.32% $0.00 14.26%
Geode Capital Management, LLC 919.89K Mar 31, 2026 2.22% $0.00 9.80%
State Street Corp 801.32K Mar 31, 2026 1.94% $0.00 -5.61%
Point72 Asset Management, L.P. 733.31K Mar 31, 2026 1.77% $0.01 -40.42%
Two Sigma Advisers, LLC 732.10K Dec 31, 2025 1.77% $0.01 0.26%

Shares Statistics

Shares Outstanding: 41.40M
Shares Float: 39.09M
% Insiders: 644.80%
% Institutions: 9,313.50%
Short % Float: 14.06%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Artisan International Small-Mid Investor 1.33M 3.21% ▲ 0.00% Mar 31, 2026
2 Artisan Non-U.S. Small-Mid Growth Comp 1.33M 3.21% ▲ 0.00% Mar 31, 2026
3 Vanguard Total Stock Mkt Idx Inv 1.23M 2.96% ▲ 0.00% Apr 30, 2026
4 iShares Russell 2000 ETF 913.33K 2.21% ▲ 0.93% May 29, 2026
5 Xtrackers MSCI World Swap ETF 1C 731.60K 1.77% ▼ 0.63% Dec 31, 2025
6 Federated Hermes MDT SCC Institutional 514.55K 1.24% ▲ 204.78% Mar 31, 2026
7 Federated Hermes MDT Small Cap Core IS 514.55K 1.24% ▲ 204.78% Mar 31, 2026
8 Vanguard Institutional Extnd Mkt Idx Tr 410.72K 0.99% ▲ 0.00% Apr 30, 2026
9 Fidelity Small Cap Index 384.16K 0.93% ▲ 12.51% Mar 31, 2026
10 iShares Russell 2000 Growth ETF 314.54K 0.76% ▼ 0.65% May 29, 2026

Valuation Metrics

Enterprise Value: $-2.14M
Trailing P/E: 0.00
Forward P/E: 116.28

Financial Highlights

Market Cap: $204.91M
EBITDA: $-52.02M
Book Value: $6.46
Earnings/Share: $-1.13
Profit Margin: -36.59%
Operating Margin: -57.71%
ROA (TTM): -11.21%
ROE (TTM): -17.06%
Revenue (TTM): $127.48M
Revenue/Share (TTM): $3.11
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -18.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 10.95x 0.00x 0.12x -1,204.75x -0.03x
2024-12-31 11.36x 0.00x 0.12x -1,755.14x -0.04x
2023-12-31 8.06x 0.01x 0.12x -15.14x -0.04x
2022-12-31 7.81x 0.47x 0.40x -12.80x -0.73x
2021-12-31 15.92x 0.33x 0.28x -14.34x -1.10x
2020-12-31 7.03x -0.09x 3.96x -69.42x 0.80x
2019-12-31 10.67x 0.00x 3.76x -1,771.92x 0.01x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RXST.US!